Cytotoxicity experiments indicated that freshly isolated CD103+ TIL were able to kill autologous tumor cells following neutralization of the PD-1–PD-L1 interaction with anti-PD-1 or anti-PD-L1 blocking antibodies (15). Here, PDCD1 is linked to neoplasm.